"Cross Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
| Descriptor ID |
D003429
|
| MeSH Number(s) |
G12.122.281
|
| Concept/Terms |
Cross Reactions- Cross Reactions
- Cross Reaction
- Reaction, Cross
- Reactions, Cross
|
Below are MeSH descriptors whose meaning is more general than "Cross Reactions".
Below are MeSH descriptors whose meaning is more specific than "Cross Reactions".
This graph shows the total number of publications written about "Cross Reactions" by people in this website by year, and whether "Cross Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 4 | 4 |
| 2004 | 1 | 3 | 4 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 4 | 4 | 8 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 6 | 6 |
| 2017 | 3 | 4 | 7 |
| 2018 | 0 | 6 | 6 |
| 2019 | 2 | 3 | 5 |
| 2020 | 2 | 7 | 9 |
| 2021 | 2 | 4 | 6 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 3 | 3 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cross Reactions" by people in Profiles.
-
Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. Nat Commun. 2026 04 15; 17(1).
-
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. Nat Microbiol. 2026 Apr; 11(4):1113-1132.
-
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein. Cell Rep Med. 2026 Feb 17; 7(2):102564.
-
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site. J Clin Invest. 2025 Dec 01; 135(23).
-
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity. J Virol. 2025 12 23; 99(12):e0125625.
-
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. Cell Rep. 2025 Aug 26; 44(8):116098.
-
Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. Nat Commun. 2024 10 30; 15(1):9403.
-
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines. Nature. 2024 06; 630(8018):950-960.
-
Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics. 2021 12 01; 148(6).
-
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 2021 08 31; 36(9):109628.